Evotec Statistics
NASDAQ: EVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.61-0.02 (-1.23%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 1.61 0.00%
Evotec by the numbers
Evotec has a market capitalization of $572.2 million based on 355.39M shares outstanding. With trailing EPS of $-0.64, Evotec is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.7% below its 50-day average and 40.0% below its 200-day average.
Average daily trading volume is 102.81K shares, or about $165,524 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EVO valuation vs. peer median
| Metric | EVO | Peer median | Difference |
|---|---|---|---|
| Market cap | $572.18M | $567.49M | +1% |
| Avg. volume | 102.81K | 1.29M | -92% |
Peer median across 8 companies: AQST, STTK, CRMD, MNPR, CTMX, PHAT, SLN, CLYM.
Valuation
- Market cap
- $572.18M
- EPS (TTM)
- $-0.64
- Shares outstanding
- 355.39M
Price and trading
- Previous close
- 1.63
- Open
- 1.60
- Day range
- 1.58 – 1.63
- 52-week range
- 1.50 – 4.27
- 52-week change
- -58.93%
- Beta
- —
- Volume
- 93.14K
- Average volume
- 102.81K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 572.18M
- Forward Pe
- -8.47
- Eps
- -0.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.27
- Week52 Low
- 1.50
- Avg Volume
- 102.81K
- Shares Outstanding
- 355.39M
- Ma50
- 1.82
- Ma200
- 2.68
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -62.30%
- Pct From52w Low
- 7.33%